PATINA supports adding palbociclib to anti-HER2 plus endocrine therapy in HR+/HER2+ disease, and HER2CLIMB-05 validates tucatinib with HP after THP induction. Sequencing trials must address ADC ...
BuzzFeed on MSN
If you're a woman in your 30s or 40s and not feeling like yourself, it might not be burnout ...
"As a culture, women have been expected to suffer through symptoms..." View Entire Post › ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果